LncRNA p53-upregulated-regulator-of-p53-levels (PURPL) contributed to chemotherapy resistance, while ASO-based knockdown significantly reduced the expression of PURPL, leading to induced cell apoptosis and sensitized cancer cell to chemotherapeutic agents (99). The gene discussed is TP53; the disease is cancer.